Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sören Weidemann, Daniel Perez, Jakob R. Izbicki, Michael Neipp, Hamid Mofid, Thies Daniels, Ulf Nahrstedt, Frank Jacobsen, Christian Bernreuther, Ronald Simon, Stefan Steurer, Eike Burandt, Andreas H. Marx, Till Krech, Till S. Clauditz & Kristina Jansen. (2021) Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. Cancer Investigation 39:9, pages 711-720.
Read now
Read now
Raúl Ortiz, José Prados, Consolación Melguizo, José L Arias, M Adolfina Ruiz, Pablo J Álvarez, Octavio Caba, Raquel Luque, Ana Segura & Antonia Aránega. (2012) 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. International Journal of Nanomedicine 7, pages 95-107.
Read now
Read now
Yu-Hung Huang, Joseph A. Cozzitorto, Nathan G. Richards, Ahmed A. Eltoukhy, Charles J. Yeo, Robert Langer, Daniel G. Anderson, Jonathan R. Brody & Janet A. Sawicki. (2010)
CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity. Cancer Biology & Therapy 10:9, pages 878-884.
Read now
Read now
Shayna L Showalter, Sarah Charles, Justin Belin, Joseph Cozzitorto, Peter Einstein, Nathan G Richards, Patricia K Sauter, Eugene P Kennedy, Agnes Witkiewicz, Jonathan R Brody & Charles J Yeo. (2010) Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future. Expert Opinion on Drug Delivery 7:3, pages 273-284.
Read now
Read now
Articles from other publishers (37)
Matteo Ardini, Riccardo Vago, Maria Serena Fabbrini & Rodolfo Ippoliti. (2022) From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?. Toxins 14:9, pages 579.
Crossref
Crossref
Sören Weidemann, Pauline Gagelmann, Natalia Gorbokon, Maximilian Lennartz, Anne Menz, Andreas M. Luebke, Martina Kluth, Claudia Hube-Magg, Niclas C. Blessin, Christoph Fraune, Katharina Möller, Christian Bernreuther, Patrick Lebok, Till S. Clauditz, Frank Jacobsen, Jakob R. Izbicki, Kristina Jansen, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Sarah Minner, Eike Burandt, Rainer H. Krech, David Dum, Till Krech, Andreas H. Marx & Ronald Simon. (2021) Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors. Biomedicines 9:4, pages 397.
Crossref
Crossref
Yuriy Khodarovich, Darya Rakhmaninova, German Kagarlitskiy, Anastasia Baryshnikova & Sergey Deyev. (2020) Growth Retardation of Poorly Transfectable Tumor by Multiple Injections of Plasmids Encoding PE40 Based Targeted Toxin Complexed with Polyethylenimine. Current Gene Therapy 20:4, pages 289-296.
Crossref
Crossref
Jiajun Xu, Muye He, Xinyu Hou, Yan Wang, Chenting Shou, Xiaoran Cai, Zeting Yuan, Yu Yin, Minbo Lan, Kaiyan Lou, Yuzheng Zhao, Yi Yang, Xianjun Chen & Feng Gao. (2019) Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology. Molecular Pharmaceutics 17:1, pages 301-315.
Crossref
Crossref
Margaret J. Lange, Terri D. Lyddon & Marc C. Johnson. (2019) Diphtheria Toxin A-Resistant Cell Lines Enable Robust Production and Evaluation of DTA-Encoding Lentiviruses. Scientific Reports 9:1.
Crossref
Crossref
Olga Kutova, Evgenii Guryev, Evgeniya Sokolova, Razan Alzeibak & Irina Balalaeva. (2019) Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency. Cancers 11:1, pages 68.
Crossref
Crossref
Amer Elias, Natasha Gritsenko, Rena Gorovits, Itay Spector, Gali Prag, Ezra Yagil & Mikhail Kolot. (2018) Anti-cancer binary system activated by bacteriophage HK022 integrase. Oncotarget 9:44, pages 27487-27501.
Crossref
Crossref
Federico Nichetti, Antonio Marra, Francesca Corti, Alessandro Guidi, Alessandra Raimondi, Natalie Prinzi, Filippo de Braud & Sara Pusceddu. (2018) The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. Targeted Oncology 13:3, pages 333-351.
Crossref
Crossref
Riccardo Vago, Veronica Collico, Stefania Zuppone, Davide Prosperi & Miriam Colombo. (2016) Nanoparticle-mediated delivery of suicide genes in cancer therapy. Pharmacological Research 111, pages 619-641.
Crossref
Crossref
Jessica Pahle & Wolfgang Walther. 2016. Current Strategies in Cancer Gene Therapy. Current Strategies in Cancer Gene Therapy
95
110
.
Baoshun Lin, Anding Gao, Rui Zhang, Hongyu Ma, Haifeng Shen, Qiong Hu, Hua Zhang, Meng Zhao, Xiaopeng Lan & Kuancan Liu. (2015) Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A. Medicine 94:31, pages e1301.
Crossref
Crossref
Renee M. TholeyShruti LalMasaya JimboRichard A. BurkhartFernando F. BlancoJoseph A. CozzitortoJosh D. EisenbergWei JiangChristine A. Iacobuzio-DonahueAgnieszka K. WitkiewiczMelissa GlbertCharles J. YeoJonathan R. BrodyJanet A. SawickiJordan M. Winter. (2015) MUC1 Promoter–Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Molecular Cancer Research 13:3, pages 439-448.
Crossref
Crossref
Andrada Seicean. (2015) New targeted therapies in pancreatic cancer. World Journal of Gastroenterology 21:20, pages 6127.
Crossref
Crossref
Zachary W. Kendrick, Matthew A. Firpo, Robert C. Repko, Courtney L. Scaife, Douglas G. Adler, Kenneth M. Boucher & Sean J. Mulvihill. (2014) Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer. HPB 16:7, pages 670-676.
Crossref
Crossref
Patricia Ohana, Imad Matouk, Doron Amit, Michal Gilon & Abraham Hochberg. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
107
122
.
Chandrashekhar D. Kamat, Ron B. Shmueli, Nick Connis, Charles M. Rudin, Jordan J. Green & Christine L. Hann. (2013)
Poly(β-amino ester) Nanoparticle Delivery of
TP53
Has Activity against Small Cell Lung Cancer
In Vitro
and
In Vivo
. Molecular Cancer Therapeutics 12:4, pages 405-415.
Crossref
Crossref
Joel C. Sunshine, Daniel Y. Peng & Jordan J. Green. (2012) Uptake and Transfection with Polymeric Nanoparticles Are Dependent on Polymer End-Group Structure, but Largely Independent of Nanoparticle Physical and Chemical Properties. Molecular Pharmaceutics 9:11, pages 3375-3383.
Crossref
Crossref
Renee Tholey, Janet A. Sawicki & Jonathan R. Brody. (2012) Molecular-Based and Alternative Therapies for Pancreatic Cancer. The Cancer Journal 18:6, pages 665-673.
Crossref
Crossref
Ron B. Shmueli, Joel C. Sunshine, Zhenhua Xu, Elia J. Duh & Jordan J. Green. (2012) Gene delivery nanoparticles specific for human microvasculature and macrovasculature. Nanomedicine: Nanotechnology, Biology and Medicine 8:7, pages 1200-1207.
Crossref
Crossref
Feng Yang, Chen Jin, Sabin Subedi, Chong Lek Lee, Qiang Wang, Yongjian Jiang, Ji Li, Yang Di & Deliang Fu. (2012) Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment. Cancer Treatment Reviews 38:6, pages 566-579.
Crossref
Crossref
Raúl Ortiz, Jose Prados, Consolación Melguizo, Ana R. Rama, Pablo J. Álvarez, Fernando Rodríguez-Serrano, Octavio Caba, Houria Boulaiz & Antonia Aranega. (2012) Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells. Biomedicine & Pharmacotherapy 66:7, pages 563-567.
Crossref
Crossref
Elena M. Glinka. (2012) Eukaryotic expression vectors bearing genes encoding cytotoxic proteins for cancer gene therapy. Plasmid 68:2, pages 69-85.
Crossref
Crossref
Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly & Peter J. Allen. (2012) A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers. PLoS ONE 7:7, pages e40157.
Crossref
Crossref
Jordan J. Green. (2012) 2011 Rita Schaffer Lecture: Nanoparticles for Intracellular Nucleic Acid Delivery. Annals of Biomedical Engineering 40:7, pages 1408-1418.
Crossref
Crossref
Katherina ZakikhanyAndroulla Efstratiou. (2012) Diphtheria in Europe: current problems and new challenges. Future Microbiology 7:5, pages 595-607.
Crossref
Crossref
Christopher M Hine, Andrei Seluanov & Vera Gorbunova. (2012) Rad51 Promoter-Targeted Gene Therapy Is Effective for In Vivo Visualization and Treatment of Cancer. Molecular Therapy 20:2, pages 347-355.
Crossref
Crossref
Jonathan R. Brody, David W. Rittenhouse, Agnieszka K. Witkiewicz & Charles J. Yeo. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
123
134.e3
.
David W. Rittenhouse, Oeendree Mukherjee, Nathan G. Richards, Charles J. Yeo, Agnieszka K. Witkiewicz & Jonathan R. Brody. 2012. Caveolins in Cancer Pathogenesis, Prevention and Therapy. Caveolins in Cancer Pathogenesis, Prevention and Therapy
43
52
.
Kyung-Dong Bae. (2011) The Evolution and Value of Diphtheria Vaccine. KSBB Journal 26:6, pages 491-504.
Crossref
Crossref
Ana R. Rama, Jose Prados, Consolacion Melguizo, Miguel Burgos, Pablo J. Alvarez, Fernando Rodriguez-Serrano, Juan L. Ramos & A. Aranega. (2011) Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells. Biomedicine & Pharmacotherapy 65:4, pages 260-270.
Crossref
Crossref
Harish Lavu & Charles J. Yeo. 2011. Current Surgical Therapy. Current Surgical Therapy
422
429
.
Assaf Shapira & Itai Benhar. (2010) Toxin-Based Therapeutic Approaches. Toxins 2:11, pages 2519-2583.
Crossref
Crossref
Nathan G. Richards, David W. Rittenhouse, Boris Freydin, Joseph A. Cozzitorto, Dane Grenda, Hallgeir Rui, Greg Gonye, Eugene P. Kennedy, Charles J. Yeo, Jonathan R. Brody & Agnieszka K. Witkiewicz. (2010) HuR Status is a Powerful Marker for Prognosis and Response to Gemcitabine-Based Chemotherapy for Resected Pancreatic Ductal Adenocarcinoma Patients. Annals of Surgery 252:3, pages 499-506.
Crossref
Crossref
Jose Prados, Consolación Melguizo, Ana Rosa Rama, Rául Ortiz, Ana Segura, Houria Boulaiz, Celia Vélez, Octavio Caba, Juan Luís Ramos & Antonia Aránega. (2009) Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells. Cancer Chemotherapy and Pharmacology 66:1, pages 69-78.
Crossref
Crossref
Joel Sunshine, Jordan J. Green, Kerry P. Mahon, Fan Yang, Ahmed A. Eltoukhy, David N. Nguyen, Robert Langer & Daniel G. Anderson. (2009) Small-Molecule End-Groups of Linear Polymer Determine Cell-type Gene-Delivery Efficacy. Advanced Materials 21:48, pages 4947-4951.
Crossref
Crossref
Raúl Ortiz, Jose Prados, Consolacion Melguizo, Ana R. Rama, Ana Segura, Fernando Rodríguez-Serrano, Houria Boulaiz, Fidel Hita, Antonio Martinez-Amat, Roberto Madeddu, Juan L. Ramos & Antonia Aranega. (2009) The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo. Journal of Molecular Medicine 87:9, pages 899-911.
Crossref
Crossref
Yu-Hung Huang, Gregory T. Zugates, Weidan Peng, David Holtz, Charles Dunton, Jordan J. Green, Naushad Hossain, Michael R. Chernick, Robert F. PaderaJr.Jr., Robert Langer, Daniel G. Anderson & Janet A. Sawicki. (2009) Nanoparticle-Delivered Suicide Gene Therapy Effectively Reduces Ovarian Tumor Burden in Mice. Cancer Research 69:15, pages 6184-6191.
Crossref
Crossref